News

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.
Novo Nordisk faces a critical phase with its obesity drug Wegovy as it confronts competition from Eli Lilly and potential job ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped ...
Novo Nordisk, the Danish drugmaker behind the popular obesity drug Wegovy, warns of fierce competition and market pressures, potentially leading to layoffs. As compounders produce cheaper copycats, U.
Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
It’s the most high-profile example yet of a controversial industry practice called preferred pharmacy networks, or PPNs ...